Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-FR Version v8-EN
Language French English
Date Updated 2019-07-05 2019-06-27
Drug Identification Number 02391678 02391678
Brand name SUBLINOX SUBLINOX
Common or Proper name SUBLINOX SUBLINOX
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size 30 30
ATC code N05CF N05CF
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-06-14 2019-06-14
Actual start date
Estimated end date 2019-06-28
Actual end date 2019-07-02
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments supplier delay supplier delay
Health Canada comments